These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1644099)

  • 1. The relative importance of blood lipids and other atherosclerosis risk factors.
    Thelle DS
    Eur Heart J; 1992 Jul; 13 Suppl B():29-33. PubMed ID: 1644099
    [No Abstract]   [Full Text] [Related]  

  • 2. Smoking and coronary atherosclerosis: follow-up study in China.
    Jia EZ; Liang J; Yang ZJ; Zhu TB; Wang LS; Chen B; Cao KJ; Huang J; Ma WZ
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):690-5. PubMed ID: 19594555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary. Relationships between serum lipids and subsequent mortality in an insured population.
    Winsemius D
    J Insur Med; 2003; 35(1):3-4. PubMed ID: 14727671
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of coronary atherosclerosis. Determination and evaluation of lipid metabolism values].
    Cremer P; Nagel D; Seidel D
    Fortschr Med; 1995 Nov; 113(32):453-8. PubMed ID: 8543271
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercholesterolaemia and coronary artery disease: A silent killer with several faces.
    Ferrières J
    Arch Cardiovasc Dis; 2019 Feb; 112(2):75-78. PubMed ID: 30606472
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of lipid regulation in the prevention of coronary heart disease.
    Bilheimer DW
    Eur Heart J; 1992 Jul; 13 Suppl B():23-8. PubMed ID: 1644098
    [No Abstract]   [Full Text] [Related]  

  • 8. The top 10 reasons cardiologists and other physicians are not interested in lipids.
    Lutschg JH
    Am J Cardiol; 1994 Jun; 73(15):1139. PubMed ID: 8198046
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between the extent of coronary atherosclerosis and lipid profile.
    Tarchalski J; Guzik P; Wysocki H
    Mol Cell Biochem; 2003 Apr; 246(1-2):25-30. PubMed ID: 12841339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between physical fitness and lifestyle behaviour in healthy young men.
    Ortlepp JR; Metrikat J; Albrecht M; Maya-Pelzer P
    Eur J Cardiovasc Prev Rehabil; 2004 Jun; 11(3):192-200. PubMed ID: 15179099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disorders of lipid metabolism and insurance medicine practice].
    Mayer-Ohly E
    Versicherungsmedizin; 1991 Jun; 43(3):65-71. PubMed ID: 1871945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Humoral investigations in coronary atherosclerosis].
    THEODORESCU B; POPESCU P; IDU SM; GHERASIM L; COCIUMIAN L; NEGRUS X; STAN M
    Med Interna (Bucur); 1960 Jul; 12():1013-20. PubMed ID: 13837702
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperlipidemia, blood coagulation factors, hereditary familial factors and coronary atherosclerosis].
    Penco M; Del Porto G; Dagianti A
    Cardiologia; 1991 Dec; 36(12 Suppl 1):15-23. PubMed ID: 1841765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic strategies for evaluating lipid metabolism disorders and therapeutic goals].
    Cremer P; Nagel D
    Internist (Berl); 1992 Jan; 33(1):32-7. PubMed ID: 1551761
    [No Abstract]   [Full Text] [Related]  

  • 15. [The importance of lipoprotein(a) as a predictive factor of coronary atherosclerosis].
    Mestre C; Grand A; Fournis Y; Mamelle N; Landrault E; Cambrillat N
    Presse Med; 1998 May; 27(18):849-54. PubMed ID: 9767868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys.
    Clarkson TB; Shively CA; Morgan TM; Koritnik DR; Adams MR; Kaplan JR
    Obstet Gynecol; 1990 Feb; 75(2):217-22. PubMed ID: 2300348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin.
    Salek L; Lutucuta S; Ballantyne CM; Gotto AM; Marian AJ
    J Mol Med (Berl); 2002 Nov; 80(11):737-44. PubMed ID: 12436350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PERSPECTIVE OF BIOLOGICAL AND OTHER FACTORS CONTRIBUTING TO CORONARY ARTERIOSCLEROSIS.
    SHAFFER CF
    Med Times; 1964 Jul; 92():664-77. PubMed ID: 14181736
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between serum lipids and subsequent mortality in an insured population.
    Ivanovic B; Pinkham CA
    J Insur Med; 2003; 35(1):11-6. PubMed ID: 14694821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum cholesterol and coronary sclerosis].
    Kaltenbach M
    Fortschr Med; 1991 Jul; 109(20):411-4. PubMed ID: 1916565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.